“…However, comparing our results to other studies introducing ERABS in the Netherlands [16,19], our complication rate is not increased. The overall complication rate in the literature is 8-18.3 % [16, 19], documented leakage rate is 0-0.8 % [16,19], bleeding 2.2-4 % [16,19] and readmissions vary between 1.3 and 8.3 % [16,19].…”